outbreak
acut
gastroenter
caus
norovirus
constitut
public
health
concern
worldwid
date
approv
drug
vaccin
manag
prophylaxi
noroviru
infect
potenti
effect
strategi
develop
noroviru
therapeut
entail
discoveri
inhibitor
noroviru
proteas
enzym
essenti
norovir
replic
describ
herein
structurebas
design
first
class
permeabl
triazolebas
macrocycl
inhibitor
noroviru
proteas
well
pertin
xray
crystallograph
biochem
spectroscop
antivir
studi
norovirus
lead
caus
foodborn
ill
us
account
million
infect
per
year
result
hospit
nearli
death
also
primari
caus
sporad
epidem
acut
gastroenter
worldwid
morbid
mortal
associ
noroviru
infect
impact
disproportion
elderli
immunocompromis
individu
develop
countri
children
combat
norovirus
present
major
challeng
norovirus
highli
contagi
genet
divers
environment
stabl
display
prolong
profus
viral
shed
evolv
rapidli
capabl
spread
mani
differ
way
current
effect
vaccin
norovirusspecif
antivir
noroviru
infect
consequ
press
need
discoveri
develop
small
molecul
therapeut
treatment
prophylaxi
noroviru
infect
noroviru
rna
viru
belong
noroviru
genu
calicivirida
famili
carri
posit
sens
singl
strand
rna
genom
kb
consist
three
open
read
frame
encod
kda
precursor
polyprotein
process
virusencod
cystein
endopeptidas
gener
least
six
matur
nonstructur
protein
polyprotein
process
noroviru
proteas
vital
replic
viru
consequ
noroviru
emerg
attract
target
discoveri
develop
antivir
agent
noroviru
infect
noroviru
chymotrypsinlik
cystein
proteas
activ
site
consist
catalyt
triad
locat
groov
sandwich
domain
domain
domain
account
bind
interact
involv
peptid
substrat
hallmark
noroviru
well
relat
viral
proteas
primari
substrat
specif
dictat
presenc
p
glutamin
less
frequent
glutam
acid
subsit
furthermor
previou
studi
involv
map
substrat
specif
reveal
proteas
prefer
small
hydrophob
amino
acid
leucin
residu
plastic
subsit
allow
proteas
accommod
gln
glu
continu
studi
area
describ
herein
structurebas
design
cellperm
macrocycl
transit
state
inhibitor
ii
figur
noroviru
well
relev
structur
biochem
spectroscop
cellbas
studi
inhibitor
reveal
peptidyl
inhibitor
noroviru
pro
bind
enzym
via
network
backbon
hydrogen
bond
mimic
antiparallel
among
hydrogen
bond
backbon
nh
carbonyl
residu
form
two
hydrogen
bond
backbon
carbonyl
nh
p
residu
inhibitor
figur
addit
third
hydrogen
bond
exist
backbon
residu
backbon
nh
p
residu
inhibitor
hydrogen
bond
arrang
resembl
hydrogen
bond
pattern
found
antiparallel
serv
correctli
orient
posit
inhibitor
substrat
backbon
activ
site
hydrogen
bond
associ
antiparallel
feasibl
inhibitor
substrat
bind
activ
site
proteas
conform
extend
saw
tooth
conform
peptid
backbon
nh
expos
environ
consequ
aforement
bind
mode
permit
proteas
univers
recogn
ligand
conform
base
forgo
recent
report
result
preliminari
studi
relat
design
triazolebas
macrocycl
inhibitor
proteas
picornaviru
noroviru
coronaviru
macrocycl
linear
peptidyl
inhibitor
accomplish
tether
p
p
residu
linear
inhibitor
suitabl
linker
therebi
preorgan
macrocycl
conform
prior
bind
enzym
activ
site
figur
approach
result
format
preorgan
semirigid
entiti
display
amino
acid
side
chain
welldefin
vector
relationship
optim
bind
enhanc
affin
inhibitor
target
enzym
minim
entropi
loss
upon
bind
addit
potenti
advantag
macrocycl
inhibitor
includ
high
stabil
metabol
enzym
high
select
frequent
increas
cellular
permeabl
describ
herein
structurebas
design
macrocycl
inhibitor
noroviru
side
chain
gln
primari
substrat
specif
residu
tether
residu
via
triazol
linker
yield
macrocycl
figur
explor
effect
ring
size
conform
impact
pharmacolog
activ
use
high
field
nmr
xray
crystallograph
studi
also
report
first
exampl
macrocycl
inhibitor
noroviru
cellurarli
permeabl
chemistri
synthesi
macrocycl
compound
tabl
intermedi
coupl
presenc
edci
hobt
yield
correspond
linear
precursor
macrocycl
ester
intramolecular
click
reaction
linear
precursor
carri
use
cuidbu
mixtur
dichloromethan
nitrogen
atmospher
room
temperatur
h
provid
macrocycl
ester
fairli
good
yield
intermedi
coupl
use
intermolecular
click
reaction
presenc
cuso
sodium
ascorb
thfh
solut
obtain
correspond
linear
precursor
macrocycl
ester
macrolactam
compound
carri
use
edci
hobt
dmf
room
temperatur
h
yield
macrocycl
ester
good
yield
cycliz
method
dilut
factor
reaction
mixtur
critic
control
intramolecular
cycliz
reaction
intermolecular
reaction
reduct
macrocycl
ester
use
libh
follow
dessmartin
periodinan
oxid
provid
correspond
macrocycl
aldehyd
fairli
good
yield
orient
triazol
ring
effect
pharmacolog
activ
conform
probe
synthes
macrocycl
via
intermedi
illustr
scheme
acycl
variant
macrocycl
synthes
accord
scheme
order
determin
effect
macrocycl
antivir
activ
dictat
primari
substrat
specif
noroviru
p
gln
residu
remain
invari
synthes
inhibitor
furthermor
noroviru
prefer
p
leu
cha
consequ
converg
natur
synthet
plan
allow
variat
p
residu
via
judici
select
appropri
natur
unnatur
amino
acid
ester
therebi
permit
target
relat
viral
proteas
picornavirida
coronavirida
famili
inhibitori
activ
compound
noroviru
vitro
noroviru
cellbas
replicon
system
evalu
previous
describ
result
summar
tabl
order
establish
precis
mechan
action
inhibitor
gain
insight
understand
structur
determin
impact
potenc
permeabl
use
facilit
structureguid
optim
pharmacolog
activ
highresolut
xray
crystal
structur
nv
bound
inhibitor
determin
attempt
obtain
crystal
structur
permeabl
inhibitor
unsuccess
preclud
structur
comparison
permeabl
nonperm
macrocycl
inhibitor
might
perhap
illumin
structur
determin
respons
observ
differ
potenc
cellular
permeabl
examin
activ
site
reveal
presenc
antiparallel
hydrogen
bond
network
associ
backbon
three
inhibitor
coval
bound
catalyt
residu
figur
coordin
ramachandran
plot
see
figur
support
inform
six
angl
pair
correspond
p
p
residu
extract
xray
crystal
structur
lie
upper
left
quadrant
plot
indic
bound
inhibitor
assum
extend
conform
pseudo
angl
p
residu
coval
bound
residu
rang
electron
densiti
map
three
bound
inhibitor
shown
figur
c
expect
backbon
three
inhibitor
structur
rigid
compar
atom
form
macrocycl
linker
flexibl
evid
analysi
bfactor
inhibitor
structur
slightli
lower
backbon
region
shown
right
panel
figur
c
electron
densiti
cap
phenyl
ring
observ
due
disord
could
model
inhibitor
somewhat
weak
electron
densiti
permit
model
phenyl
ring
triazol
ring
inhibitor
reason
electron
densiti
howev
disord
exact
orient
clearli
discern
figur
tabl
indic
except
compound
rest
compound
display
low
micromolar
ic
valu
observ
degre
inhibit
prompt
us
delin
structur
determin
associ
bind
order
gain
insight
understand
rel
potenc
inhibitor
toward
end
superposit
gesamt
highresolut
xray
crystal
structur
nv
complex
largest
ring
size
nv
complex
smallest
ring
size
show
enzym
structur
complex
similar
rmsd
atom
residu
except
flexibl
loop
span
figur
bind
inhibitor
larger
ring
size
activ
site
accompani
movement
flexibl
loop
away
inhibitor
result
loss
hydrogen
bond
p
side
chain
gln
co
inhibitor
backbon
nh
form
pocket
constitu
pocket
part
flexibl
loop
maintain
hydrogen
bond
interact
p
gln
co
figur
note
interact
nv
acycl
dipeptidyl
tripeptidyl
inhibitor
involv
format
two
crucial
hydrogen
bond
carbonyl
oxygen
glutamin
surrog
co
inhibitor
residu
two
hydrogen
bond
interact
well
flexibl
backbon
loop
appear
play
critic
role
enzymesubstr
recognit
conserv
noroviru
proteas
thu
nv
complex
movement
flexibl
loop
shorter
linker
length
inhibitor
posit
carbonyl
oxygen
p
gln
side
chain
away
result
loss
p
gln
co
hydrogen
bond
figur
convers
bind
inhibitor
allow
flexibl
loop
move
closer
inhibitor
contact
form
carbonyl
oxygen
warhead
figur
compact
natur
inhibitor
posit
nh
group
p
gln
side
chain
within
hydrogen
bond
distanc
carbonyl
oxygen
residu
see
figur
support
inform
distanc
inform
relat
hydrogen
bond
subtl
structur
shift
associ
gln
side
chain
may
account
lower
inhibitori
activ
observ
seri
macrocycl
triazol
compound
compar
previous
report
triazolebas
macrocycl
calpain
inhibitor
specif
macrocycl
inhibitor
gener
former
case
potenc
sole
depend
combin
effect
hydrophob
interact
network
hydrogen
bond
interact
inhibitor
backbon
enzym
activ
site
facilit
conform
inhibitor
enhanc
ic
valu
associ
replac
p
isobutyl
side
chain
cyclohexyl
group
observ
linear
dipeptidyl
inhibitor
diminish
compound
ic
partli
due
loss
key
hydrogen
bond
interact
reveal
xray
crystal
structur
larger
flexibl
ring
see
discuss
nmr
studi
hand
mention
compact
rigid
ring
structur
addit
hydrogen
bond
discern
xray
crystal
structur
may
account
decreas
ic
summari
interact
macrocycl
inhibitor
nv
induc
conform
chang
flexibl
loop
activ
site
enzym
depend
macrocycl
ring
size
structur
chang
result
suboptim
angl
distanc
form
critic
intermolecular
hydrogen
bond
gln
side
chain
activ
site
residu
consequ
maxim
bind
potenc
effect
compens
energi
penalti
requir
desolv
molecul
attain
order
gain
insight
solut
conform
bind
synthes
macrocycl
inhibitor
well
confirm
absenc
altern
structur
nmr
studi
carri
use
precursor
cyclic
ester
assign
proton
reson
done
use
h
cosi
roesi
hmbc
spectral
detail
roesi
spectra
compound
show
h
nh
type
correl
gln
leu
nh
show
correl
leu
carbam
respect
see
figur
support
inform
observ
indic
prearrang
structur
within
macrocycl
temperatur
depend
amid
nh
chemic
shift
experi
perform
use
compound
ring
size
ring
size
ring
size
reveal
import
inform
solut
structur
macrocycl
solvent
shield
nh
proton
typic
valu
less
ppbk
solvent
expos
nh
proton
valu
greater
ppbk
accord
result
gln
leu
propargylglycin
nh
proton
valu
greater
ppbk
case
tabl
larger
ring
size
carbam
nh
show
higher
temperatur
depend
ppbk
ring
size
respect
indic
greater
solvent
exposur
howev
smaller
ring
size
show
compar
low
temperatur
depend
ppbk
ring
size
indic
less
solvent
exposur
support
observ
line
broaden
carbam
nh
proton
elev
temperatur
compound
lower
line
broaden
observ
figur
support
inform
previou
studi
shown
amid
signal
exchang
water
impur
present
dmso
solvent
show
consider
broaden
line
width
elev
temperatur
due
enhanc
exchang
rate
higher
temperatur
smaller
ring
size
three
nh
proton
show
less
temperatur
depend
indic
solvent
shield
partli
due
compact
natur
compound
absenc
low
temperatur
depend
nh
proton
ppbk
would
appear
rule
presenc
altern
turn
structur
final
conform
peptid
backbon
macrocycl
determin
base
j
coupl
constant
tabl
coupl
constant
j
correl
dihedr
angl
accord
karplu
equat
unstructur
random
coil
conform
coupl
constant
around
hz
unusu
high
coupl
constant
hz
observ
wellstructur
accord
result
shown
tabl
expect
conform
observ
ring
studi
describ
herein
demonstr
feasibl
gener
cellperm
triazolebas
macrocycl
inhibitor
noroviru
proteas
valuabl
insight
mechan
action
conform
pharmacolog
activ
gain
use
array
structur
spectroscop
antivir
techniqu
methodolog
interact
inhibitor
nv
result
subtl
structur
shift
activ
site
topographi
impair
hydrogen
bond
interact
gln
residu
inhibitor
key
amino
acid
residu
contribut
lower
pharmacolog
activ
result
ongo
studi
like
illumin
interplay
ring
size
conform
cellular
permeabl
report
due
cours
solut
nboc
protect
alcohol
mmol
tea
mmol
dri
dcm
ml
kept
ice
bath
c
slowli
ad
methan
sulfonyl
chlorid
mmol
reaction
mixtur
stir
minut
c
ice
bath
remov
reaction
mixtur
allow
stir
room
temperatur
hour
complet
reaction
monitor
tlc
water
ml
ad
stir
result
solut
transfer
reparatori
funnel
organ
layer
separ
aqueou
layer
extract
dcm
x
ml
boclpropargylglycin
g
mmol
dri
dmf
ml
react
lleuom
hcl
mmol
accord
gener
procedur
crude
product
purifi
use
flash
chromatographi
silica
gel
hexaneethyl
acet
give
white
solid
g
yield
mp
c
compound
prepar
use
similar
procedur
one
describ
compound
g
mmol
dri
ch
cl
ml
treat
hcl
dioxan
remov
boc
protect
accord
gener
procedur
c
solvent
remov
reaction
high
vacuum
dryness
solut
result
compound
prepar
accord
procedur
white
solid
g
yield
mp
c
compound
prepar
use
procedur
describ
colorless
oil
compound
g
mmol
dissolv
dri
dmf
ml
convert
azid
accord
gener
procedur
e
yield
light
yellow
oil
g
yield
solut
compound
g
mmol
dri
ch
cl
ml
treat
hcl
dioxan
remov
boc
protect
accord
gener
procedur
c
solvent
remov
reaction
high
vacuum
dryness
result
compound
bocgluom
g
mmol
dri
dmf
ml
react
compound
g
mmol
accord
gener
procedur
crude
product
purifi
compound
prepar
use
procedur
describ
colorless
oil
compound
prepar
use
procedur
describ
compound
prepar
use
procedur
describ
compound
prepar
use
procedur
describ
compound
prepar
use
procedur
describ
compound
prepar
use
procedur
describ
z
hydroxymethyl
white
solid
g
yield
mp
c
coordin
structur
factor
deposit
worldwid
protein
databank
